SLC44A2 and COVID-19: Up to this point there is no data available on SLC44A2 in COVID-19 and how it could potentially impact CAC except for fundamental proteomic data which suggests a significant downregulation of SLC44A2 in neutrophils from severe COVID-19 patients (90).